No one seems to mention the status of the GOG test for cervical cancer or the CRUK study for Head and Neck cancer. Both of these enrolled patients but it appears the studies are slow moving . However if proof of concept comes out of the Cin mid dose, perhaps the powers that be will have more confidence in treating more patients. in these two studies.. TM also mentioned the company starting Phase ll studies in Prostrate, Breast Caner, and Anal Cancer. If a partnership agreement is reached and the company receives funding, I am sure these studies will be initiated. With 5 or 6 studies going on in the possible near future, , ADXS will have lots of developing news stories to maintain investor interest.